Gram Positive Bacterial Infections clinical trials at UCLA

1 in progress, 0 open to eligible people

Oritavancin in Pediatric Patients With Suspected or Confirmed Bacterial Infections
Sorry, in progress, not accepting new patients
The purpose of this Phase 1 trial is to evaluate the pharmacokinetics, safety and tolerability of oritavancin in patients <18 years old with a confirmed or suspected bacterial infection.
Torrance, California and other locations

Last updated: July 24, 2025